{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:01Z","timestamp":1794047461606,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"6","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2023.284286","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T03:10:23Z","timestamp":1706152223000},"page":"1960-1965","source":"Crossref","is-referenced-by-count":1,"title":["Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma"],"prefix":"10.3324","volume":"109","author":[{"given":"Gaurav","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Sadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherin","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Y","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemma","family":"Larham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluremi","family":"Carty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Koshiaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaimal","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Bowcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Oppermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Gamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chara","family":"Kyriakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Drayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supratik","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelagh","family":"McKinley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gooding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad K","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"62451","doi-asserted-by":"crossref","unstructured":"Chari A, Kemal Samur M, Martinez-Lopez J. Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set. Blood. 2020; 136(26):3033-3040.","DOI":"10.1182\/blood.2020008150"},{"key":"62452","doi-asserted-by":"crossref","unstructured":"Ramasamy K, Sadler R, Jeans S. Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T-cell response. Br J Haematol. 2022; 197(3):293-301.","DOI":"10.1111\/bjh.18066"},{"key":"62453","doi-asserted-by":"crossref","unstructured":"Aleman A, Upadhyaya B, Tuballes K. Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma. Cancer Cell. 2021; 39(11):1442-1444.","DOI":"10.1016\/j.ccell.2021.09.015"},{"key":"62454","doi-asserted-by":"crossref","unstructured":"Van Oekelen O, Gleason CR, Agte S. Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma. Cancer Cell. 2021; 39(8):1028-1030.","DOI":"10.1016\/j.ccell.2021.06.014"},{"key":"62455","doi-asserted-by":"crossref","unstructured":"Ramasamy K, Sadler R, Jeans S. COVID symptoms, testing, shielding impact on patient-reported outcomes and early vaccine responses in individuals with multiple myeloma. Br J Haematol. 2022; 196(1):95-98.","DOI":"10.1111\/bjh.17764"},{"key":"62456","doi-asserted-by":"crossref","unstructured":"Chuleerarux N, Manothummetha K, Moonla C. Immunogenicity of SARS-CoV-2 vaccines in patients with multiple myeloma: a systematic review and meta-analysis. Blood Adv. 2022; 6(24):6198-6207.","DOI":"10.1182\/bloodadvances.2022008530"},{"key":"62457","doi-asserted-by":"crossref","unstructured":"Schmidt T, Klemis V, Schub D. Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19\/mRNA vaccination. Nat Med. 2021; 27(9):1530-1535.","DOI":"10.1038\/s41591-021-01464-w"},{"key":"62458","doi-asserted-by":"crossref","unstructured":"Borobia AM, Carcas AJ, P\u00e9rez-Olmeda M. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet. 2021; 398(10295):121-130.","DOI":"10.1016\/S0140-6736(21)01420-3"},{"key":"62459","doi-asserted-by":"crossref","unstructured":"Andrews N, Stowe J, Kirsebom F. Covid-19 Vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl J Med. 2022; 386(16):1532-1546.","DOI":"10.1056\/NEJMoa2119451"},{"key":"62460","doi-asserted-by":"crossref","unstructured":"Naranbhai V, Garcia-Beltran WF, Chang CC. Comparative Immunogenicity and effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines. J Infect Dis. 2022; 225(7):1141-1150.","DOI":"10.1093\/infdis\/jiab593"},{"key":"62461","doi-asserted-by":"crossref","unstructured":"Goldwater MS, Stampfer SD, Sean Regidor B. Third dose of an mRNA COVID-19 vaccine for patients with multiple myeloma. Clin Infect Pract. 2023; 17:100214.","DOI":"10.1016\/j.clinpr.2022.100214"},{"key":"62462","doi-asserted-by":"crossref","unstructured":"Stampfer SD, Goldwater MS, Jew S. Response to mRNA vaccination for COVID-19 among patients with multiple myeloma. Leukemia. 2021; 35(12):3534-3541.","DOI":"10.1038\/s41375-021-01354-7"},{"key":"62463","doi-asserted-by":"crossref","unstructured":"Storti P, Marchica V, Vescovini R. Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response. Oncoimmunology. 2022; 11(1):2120275.","DOI":"10.1080\/2162402X.2022.2120275"},{"key":"62464","doi-asserted-by":"crossref","unstructured":"Tortorella C, Aiello A, Gasperini C. Humoral and T-cell-specific immune responses to SARS-CoV-2 mRNA vaccination in patients with MS using different disease-modifying therapies. Neurology. 2022; 98(5):e541-e554.","DOI":"10.1212\/WNL.0000000000013108"},{"key":"62465","doi-asserted-by":"crossref","unstructured":"Faustini SE, Hall A, Brown S. Immune responses to COVID-19 booster vaccinations in intensively anti-CD38 antibody treated patients with ultra-high-risk multiple myeloma: results from the Myeloma UK (MUK) nine OPTIMUM trial. Br J Haematol. 2023; 201(5):845-850.","DOI":"10.1111\/bjh.18714"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284286\/76511","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284286\/77086","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11418\/76511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:05:35Z","timestamp":1794045935000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.284286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":15,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.284286","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,25]]}}}